<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04612400</url>
  </required_header>
  <id_info>
    <org_study_id>260813</org_study_id>
    <nct_id>NCT04612400</nct_id>
  </id_info>
  <brief_title>Whole Body Protein Metabolism of a Whey/EAA Supplement Using Continuous Oral Stable Isotopes</brief_title>
  <official_title>Whole Body Protein Metabolism of a Whey/EAA Supplement Using Continuous Oral Stable Isotopes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arkansas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Arkansas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the validity of a continuous oral sip-feeding method of stable isotope tracer for&#xD;
      the evaluation of whole-body protein metabolism in response to two different doses of an&#xD;
      EAA/whey protein supplement (Low=6.3g and High=12.6g). Results will be compared to those&#xD;
      previously determined by constant infusion with the same EAA/whey supplement.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a double-blinded, randomized, crossover pilot study to evaluate the validity of&#xD;
      a continuous oral sip-feeding of stable isotope tracer method for the evaluation of&#xD;
      whole-body protein metabolism. This method will be evaluated using two different amounts of&#xD;
      an essential amino acid (EAA) + whey protein supplement on up to six younger, healthy&#xD;
      subjects. Stable isotope preparations will be continuously consumed by subjects throughout&#xD;
      visits 2 and 3 to enable whole body protein metabolism to be measured.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 4, 2020</start_date>
  <completion_date type="Actual">September 6, 2021</completion_date>
  <primary_completion_date type="Actual">September 6, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>double-blinded, randomized, crossover pilot study</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>This will be a double-blinded study. Both SP amounts are dissolved into equal volumes of water so that subjects will not know which amount they are ingesting. Blood samples are coded so that lab staff and investigators will not know which amount of SP was consumed at each visit. Investigators will be unblinded after all samples have been processed and data analysis has taken place.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Whole-body protein net balance</measure>
    <time_frame>240 minutes</time_frame>
    <description>grams of protein per 240 minutes</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Low</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low dose (6.3g) EAA/whey protein supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High dose (12.6g) EAA/whey protein supplement</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oral amino acid tracer</intervention_name>
    <description>Whole body protein metabolism response to a dose of the supplement will be measured using a continuous oral sip-feeding (every 10 minutes) method of stable isotope tracer.</description>
    <arm_group_label>High</arm_group_label>
    <arm_group_label>Low</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 21-40 years.&#xD;
&#xD;
          -  Body weight of â‰¤ 80kg.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History Chronic kidney disease.&#xD;
&#xD;
          -  History of dairy allergy or intolerance.&#xD;
&#xD;
          -  History of gastric reduction/bypass surgery.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arny A Ferrando, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Arkansas</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Center of Translational Research in Aging and Longevity</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 27, 2020</study_first_submitted>
  <study_first_submitted_qc>October 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 3, 2020</study_first_posted>
  <last_update_submitted>October 19, 2021</last_update_submitted>
  <last_update_submitted_qc>October 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stable Isotopes</keyword>
  <keyword>Validation</keyword>
  <keyword>Whole-body protein metabolism</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No IPD will be shared with other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

